SG11201900424SA - Organic compounds - Google Patents

Organic compounds

Info

Publication number
SG11201900424SA
SG11201900424SA SG11201900424SA SG11201900424SA SG11201900424SA SG 11201900424S A SG11201900424S A SG 11201900424SA SG 11201900424S A SG11201900424S A SG 11201900424SA SG 11201900424S A SG11201900424S A SG 11201900424SA SG 11201900424S A SG11201900424S A SG 11201900424SA
Authority
SG
Singapore
Prior art keywords
international
shanghai
pct
road
publication
Prior art date
Application number
SG11201900424SA
Other languages
English (en)
Inventor
Yue Zou
An Chai
Jie Liu
Lijun Zhou
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of SG11201900424SA publication Critical patent/SG11201900424SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0042—Essential oils; Perfumes compounds containing condensed hydrocarbon rings
    • C11B9/0046—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings
    • C11B9/0049—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50—Perfumes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Detergent Compositions (AREA)
SG11201900424SA 2016-08-15 2017-08-14 Organic compounds SG11201900424SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2016095273 2016-08-15
PCT/EP2017/070593 WO2017191331A2 (en) 2016-08-15 2017-08-14 Organic compounds

Publications (1)

Publication Number Publication Date
SG11201900424SA true SG11201900424SA (en) 2019-02-27

Family

ID=59702687

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201900424SA SG11201900424SA (en) 2016-08-15 2017-08-14 Organic compounds

Country Status (8)

Country Link
US (1) US11020333B2 (enExample)
EP (1) EP3497192B1 (enExample)
JP (1) JP7036796B2 (enExample)
CN (1) CN109563438B (enExample)
ES (1) ES2908129T3 (enExample)
MX (1) MX384407B (enExample)
SG (1) SG11201900424SA (enExample)
WO (1) WO2017191331A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017191331A2 (en) 2016-08-15 2017-11-09 Givaudan Sa Organic compounds
US10494323B2 (en) * 2016-08-15 2019-12-03 Givaudan Sa Process for the preparation of indanones

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5248200B2 (enExample) * 1973-04-13 1977-12-08
US3944679A (en) 1973-04-13 1976-03-16 The Japan Tobacco & Salt Public Corporation Process for imparting a coumarin-like aroma and flavor to tobacco, foods and drinks
US4572796A (en) 1984-05-24 1986-02-25 International Flavors & Fragrances Inc. 1,1,4,7-Tetramethyl-3-indanone, product produced thereby and organoleptic uses thereof
US5012007A (en) * 1989-10-05 1991-04-30 Varadaraj Elango Method for producing 1-indanone derivatives
DE59303229D1 (de) * 1992-04-28 1996-08-22 Hoechst Ag Verfahren zur Herstellung substituierter Indanone und ihre Verwendung
DE59308494D1 (de) 1992-08-03 1998-06-10 Targor Gmbh Verfahren zur Herstellung eines Olefinpolymers unter Verwendung von Metallocenen mit speziell substituierten Indenylliganden
DE69516036T2 (de) * 1994-05-31 2000-12-21 Firmenich S.A., Genf/Geneve Aromatische Verbindungen und ihre Verwendung in der Parfümerie
US5998477A (en) 1996-06-13 1999-12-07 Cell Pathways Inc. Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
ES2195500T3 (es) * 1999-01-22 2003-12-01 Firmenich & Cie Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes.
DE10155554A1 (de) 2001-11-12 2003-05-22 Haarmann & Reimer Gmbh 6-Alkylindan-1-0ne als Riechstoffe
EP1340741A1 (en) * 2002-02-28 2003-09-03 Givaudan SA Indane derivatives and their use in perfumery
JP4147302B2 (ja) * 2003-09-26 2008-09-10 独立行政法人産業技術総合研究所 １−インダノン類の製造方法
GB201115409D0 (en) * 2011-09-07 2011-10-19 Givaudan Sa Organic compounds
JP6333251B2 (ja) 2012-08-16 2018-05-30 バイエル ファーマ アクチエンゲゼルシャフト ２，３−ベンゾジアゼピン類
EP3301098B1 (en) 2012-12-21 2020-02-19 Borealis AG Process for the preparation of a ligand for a catalyst
EP3245185B1 (en) * 2015-01-12 2019-03-13 Firmenich SA Intermediate compounds for producing perfuming ingredients
WO2017191331A2 (en) 2016-08-15 2017-11-09 Givaudan Sa Organic compounds

Also Published As

Publication number Publication date
WO2017191331A2 (en) 2017-11-09
JP7036796B2 (ja) 2022-03-15
EP3497192A2 (en) 2019-06-19
MX2019001303A (es) 2019-06-17
CN109563438A (zh) 2019-04-02
ES2908129T3 (es) 2022-04-27
MX384407B (es) 2025-03-14
US11020333B2 (en) 2021-06-01
WO2017191331A3 (en) 2017-12-14
EP3497192B1 (en) 2021-12-22
JP2019532123A (ja) 2019-11-07
CN109563438B (zh) 2022-11-04
US20200330346A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
SG11201804170RA (en) Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
SG11201809559UA (en) Substituted pyridines as inhibitors of dnmt1
SG11201909615YA (en) Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same
SG11201909825VA (en) Hsp90 inhibitor oral formulations and related methods
SG11201804890TA (en) Bipyrazolyl derivatives useful for the treatment of autoimmune diseases
SG11201408791TA (en) Dihydropyrimidine compounds and their application in pharmaceuticals
SG11201806863WA (en) Tetracyclic pyridone compounds as antivirals
SG11201806583XA (en) Compositions containing tucaresol or its analogs
SG11201810429UA (en) Anti-cd19 antibody formulations
SG11201903427UA (en) Deodorizing agent comprising zinc neodecanoate
SG11201408237YA (en) Compound as wnt signaling inhibitor, composition, and use thereof
SG11201808566WA (en) Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201804223TA (en) OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201811708QA (en) Process for the preparation of microcapsules
SG11201809497RA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201407337QA (en) Cyclodextrin complexation methods for formulating peptide proteasome inhibitors
SG11201901438VA (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
SG11201909263XA (en) Improvements in or relating to organic compounds
SG11201407988UA (en) Process for improved opioid synthesis
SG11201804774YA (en) Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031
SG11201808686VA (en) Synthesis of indazoles
SG11201900043TA (en) Antibody formulations
SG11201908235RA (en) An isoxazole derivatives as nuclear receptor agonists and used thereof